From: Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
AE grade | System Organ Class (SOC)/AE type | AE outcome | Treatment interruption | Improvement after interr | Treatment restart | Alternative cause for AE | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General disorders | Vascular disorders | Musculo-Skeletal disorders | Nervous System & Psychiatric disorders | Renal disorders | Gastroint. disorders | Reproduct system disorders | Skin disorders | |||||||
BZB | 1 | 1 enlarged PAVM | 1 joint pain 1 facial pain | 2 hair loss | 1 unresolved/worsened 4 resolved | 1 Yes 4 No | 1 No | 1 No | In 2 | |||||
2 | 1 fatigue | 2 hypertension | 6 joint pain 1 vertebral fracture | 1 confusion 3 headaches | 2 proteinuria | 1 diarrhea | 17 resolved | 17 No | In 1 | |||||
3 | 1 fatigue | 3 hypertension 1 arterial thrombosisa | 2 joint pain | 1 confusion | 1 GI bleedingb 1 diarrhea | 1 unresolved/worsened 9 resolved | 3 Yes 7 No | 2 Yes 1 No | 1 Yes 2 No | In 2 | ||||
TH | 1 | 5 peripheral neuropathyc 1 somnolence 1 drowsiness | 1 rash | 2 unresolved/worsened 6 resolved | 3 Yes 5 No | 3 Yes | 3 No | none | ||||||
2 | 5 peripheral neuropathyd 4 dizziness 2 somnolence 7 drowsiness | 1 constipation | 1 erectile dysfunction | 7 unresolved/worsened 2 resolved with sequelae 11 resolved | 15 Yes 5 No | 10 Yes 5 No | 15 No | none | ||||||
3 | 1 limb edema | 1 arterial thrombosisf | 2 peripheral neuropathy & 2 dizziness | 4 unresolved/worsened 2 resolved | 4 Yes 2 No | 2 Yes 2 No | 1 Yes 3 No | In 1 |